Distalmotion is a global MedTech company with a mission to empower access to the benefits of robotic surgery by simplifying operations with its DEXTER robot. The company aims to broaden access to robotic surgery for more surgeons and sites of care globally, including hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs), to increase the number of patients who benefit from best-in-class minimally invasive care.
Distalmotion LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Distalmotion had 219 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Distalmotion had 32,827 followers as of November 2, 2026. The number of followers increased by 329 (1.01%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 18, 2025 | Series G | $150.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Revival Healthcare Capital | Series G |
A snapshot of private companies similar to Distalmotion, helping you discover and navigate related company profiles.


